You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -18.1 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 22.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-04-30 | n/a | -4.50 | -1.33p | -9.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | n/a | -4.94 | -1.31p | -9.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | n/a | -6.71 | -1.42p | -3.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-04-30 | n/a | -6.77 | -1.18p | -6.7 | 0.0 | n/a | n/a | 0.0% |
| Scancell gets MHRA approval for Modi-1 clinical trial Sharecast News | 26 Aug |
|---|---|
| Scancell chooses needle-free tech for Covid vaccine candidates Sharecast News | 17 Aug |
| Scancell makes progress with 'Covidity' trial plans Sharecast News | 22 Jun |
| New facilities at The Oxford Science Park | 19-Oct-21 07:00 |
|---|---|
| Notice of Final Results | 15-Oct-21 07:00 |
| First subject dosed in COVIDITY clinical trial | 05-Oct-21 16:23 |
| PDMR dealing | 09-Sep-21 16:32 |
| Modi-1 Phase I/II CTA approved by MHRA | 26-Aug-21 07:00 |